Ara
Toplam kayıt 4, listelenen: 1-4
The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow
(Akademiai Kiado Zrt, 2016)
Background: Slow coronary flow (SCF) is an angiographic finding characterized with delayed opacification of epicardial coronary arteries without obstructive coronary disease. Urotensin II (UII) is an important vascular ...
Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study
(2013)
Amaç: Koroner yavaş akım (KYA) epikardiyal koroner arterlerin obstrüktif hastalık olmaksızın yavaş dolması ile karakterize bir durumdur. CD40/ CD40 ligandı (CD40L) sistemi artmış enflamasyon ve protrombotik yatkınlık ...
Increased epicardial adipose tissue in patients with slow coronary flow phenomenon
(Via Medica, 2012)
Background: Slow coronary flow (SCF) is an angiographic finding characterised by delayed opacification of epicardial coronary arteries without obstructive coronary disease. Epicardial adipose tissue (EAT), localised beneath ...
Increased serum resistin levels in patients with coronary slow-flow phenomenon
(Urban und Vogel GmbH, 2013)
Background. Slow coronary flow (SCF) is an angiographic finding characterized by delayed opacification of the epicardial coronary arteries without obstructive coronary disease. Resistin, an adipocytokine, plays a major ...
